# FDA Inspection 1041217 - Mid South Biologics, LLC - February 16, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/mid-south-biologics-llc/8018c4f3-9ec7-47e0-9b8e-be1b4c2f685e
Source feed: FDA_Inspections

> FDA Inspection 1041217 for Mid South Biologics, LLC on February 16, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1041217
- Company Name: Mid South Biologics, LLC
- Inspection Date: 2018-02-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 983193 - 2016-06-17](https://www.globalkeysolutions.net/records/fda_inspections/mid-south-biologics-llc/838551ce-f7e4-41a6-a081-2b8a36ae71dd)
- [FDA Inspection 886441 - 2014-06-26](https://www.globalkeysolutions.net/records/fda_inspections/mid-south-biologics-llc/57f97b78-4d8f-4947-9ff7-fcebdf6c2c07)
- [FDA Inspection 723219 - 2011-05-02](https://www.globalkeysolutions.net/records/fda_inspections/mid-south-biologics-llc/f9e4d685-0de4-4ba2-a9cd-a8bff465a1f5)

Company: https://www.globalkeysolutions.net/companies/mid-south-biologics-llc/3e0a163f-6765-4298-8d9d-5fe8b6b7190e

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d